Universidad de Granada

Granada, Spain

Event Information



Monday, September 24, 2018


Sala de Claustro
Facultad de Ciencias
Campus de Fuentenueva, s/n
Universidad de Granada
18071 Granada


Universidad de Granada


ACS on Campus, the American Chemical Society’s flagship outreach program, is proud to partner with Universidad de Granada on September 24! Our sessions will introduce you to publishing and informatics processes, and contribute to your professional development. You’ll benefit from exposure to ACS editors and networking opportunities with local professionals and your peers. Don’t miss out on career advice from local professionals during our Careers in Chemistry panel discussion! 

You’ll hear from Prof. Félix Calderon, Associate Editor, ACS Infectious Diseases, Dr. Míriam Plana of ACS International, and more!

The event is FREE and open to all students studying the sciences – not just chemistry! Registration is recommended. 


ACS Infectious Diseases



Badge Collection


Opening Remarks


“Tres Cantos Open Lab: Filling the Translational Gap in Neglected Diseases Drug Discovery” from. Dr. Félix Calderón

The drug discovery process for the diseases of the developing world (DDW) in the pharmaceutical industry is challenging due to the large investment and low financial return. Therefore, innovative strategies are required to discover and develop new pharmaceuticals against Diseases of the Developing World.

Since 2010, GlaxoSmithKline has adopted an open innovation strategy promoting collaboration and transfer of knowledge among the scientific community, with the final aim to deliver new effective medicines for the DDW. Within our open innovation approach, the Open Lab program has been created to facilitate the translation of basic research in the DDW field into industrial scale. The Open Lab offers the GSK Tres Cantos site (Spain) to scientists from around the world to work on their own DDW projects, providing them the drug discovery expertise and state-of-the-art facilities of the pharmaceutical industry. Results are shared with the broader community to accelerate and motivate research in DDW.

Over the last seven years, the Open Lab has funded more than 72 projects and has hosted more than 85 visiting scientists from world class institutions. Focused on developing tools, exploiting targets and discovering novel molecules to tackle malaria, tuberculosis, kinetoplastid and enteric diseases, the Openlab is delivering exciting drug discovery opportunities that could deliver new effective medicines for the least developed countries.


Using SciFinder in Your Job Search


Top 10 Tips for Scholarly Publishing




Careers in Chemistry – Panel Discussion


Closing Remarks & ACS Resources to Grow Your Future


Coffee Break